These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 15234130)

  • 1. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M;
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
    Submacular Surgery Trials Research Group
    Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
    Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
    Maguire MG; Alexander J; Fine SL;
    Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
    Complications of Age-Related Macular Degeneration Prevention Trial Research Group
    Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH; Nordmann JP; Colin E; Arnould B
    Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25).
    Toprak AB; Eser E; Guler C; Baser FE; Mayali H
    Ophthalmic Epidemiol; 2005 Aug; 12(4):259-69. PubMed ID: 16033747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
    Orr P; Rentz AM; Margolis MK; Revicki DA; Dolan CM; Colman S; Fine JT; Bressler NM
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3354-9. PubMed ID: 21282568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT; Banks AD; Stinnett SS; Toth CA
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
    Hudson HL; Lane SS; Heier JS; Stulting RD; Singerman L; Lichter PR; Sternberg P; Chang DF;
    Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
    Suñer IJ; Kokame GT; Yu E; Ward J; Dolan C; Bressler NM
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire.
    Awdeh RM; Elsing SH; Deramo VA; Stinnett S; Lee PP; Fekrat S
    Br J Ophthalmol; 2010 Mar; 94(3):319-23. PubMed ID: 19737736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients.
    Noble J; Forooghian F; Sproule M; Westall C; O'Connor P
    Am J Ophthalmol; 2006 Sep; 142(3):464-8. PubMed ID: 16935592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
    Sunness JS; Gonzalez-Baron J; Applegate CA; Bressler NM; Tian Y; Hawkins B; Barron Y; Bergman A
    Ophthalmology; 1999 Sep; 106(9):1768-79. PubMed ID: 10485549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
    Cole SR; Beck RW; Moke PS; Gal RL; Long DT
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.